mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-07 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-07 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-07 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-07 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-06 |